CONMED Corporation reported $1.37B of revenue over the trailing twelve months, +3.4% on the year before. 11 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $1.37B (to Q2 2026). Net income: $56M, trailing twelve months to Q2 2026. Free cash flow: $151M, trailing twelve months to Q4 2025. Operating margin: 8.0%, trailing twelve months to Q2 2026.

CNMDCONMED Corporation

Healthcare

$44.43-11% 1Y

$44.43

$32.1152 weeks$51.88

CNMD as reported

CONMED Corporation reported $1.37B of revenue over the trailing twelve months, +3.4% on the year before. 11 reported series are charted on this page, each one as filed.

$1.37B

Revenue, trailing twelve months · to Q2 2026 · +3.4% against the twelve months before

Net income: $56M
Net income · −49% year on year · trailing twelve months to Q2 2026
Free cash flow: $151M
Free cash flow · trailing twelve months to Q4 2025
Operating margin: 8.0%
Operating margin · trailing twelve months to Q2 2026

Details›

Every series Ryufin has for CNMD, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$1.37B	+3.4%	Q2 2026
Net income	$56M	−49%	Q2 2026
EPS	$1.85	−48%	Q2 2026
Gross margin	56%	n/a	Q2 2026
Operating margin	8.0%	n/a	Q2 2026
Net margin	4.1%	n/a	Q2 2026
ROE	5.4%	n/a	Q2 2026
ROA	3.7%	n/a	Q4 2025
ROIC	6.2%	n/a	Q4 2025
Free cash flow	$151M	n/a	Q4 2025
P/E	24.0	n/a	today

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.